Reports Details
The global Active Pharmaceutical Ingredients (API) market was valued at $XX million in 2018, and Global Research View analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028.
This report provides detailed historical analysis of global market for Active Pharmaceutical Ingredients (API) from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Active Pharmaceutical Ingredients (API) market.
Leading players of Active Pharmaceutical Ingredients (API) including:
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy?s Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC
Market split by Type, can be divided into:
Synthetic APIs
Biotech APIs
Market split by Application, can be divided into:
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel
Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America Brazil, Argentina, Colombia and Chile etc.)
Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)
If you have any special requirement, please let us know and we can provide you the report as your requirement.
Table of Content
Table of Contents
Chapter 1 Active Pharmaceutical Ingredients (API) Market Overview
1.1 Active Pharmaceutical Ingredients (API) Definition
1.2 Global Active Pharmaceutical Ingredients (API) Market Size Status and Outlook (2021-2026)
1.3 Global Active Pharmaceutical Ingredients (API) Market Size Comparison by Region (2021-2026)
1.4 Global Active Pharmaceutical Ingredients (API) Market Size Comparison by Type (2021-2026)
1.5 Global Active Pharmaceutical Ingredients (API) Market Size Comparison by Application (2021-2026)
1.6 Global Active Pharmaceutical Ingredients (API) Market Size Comparison by Sales Channel (2021-2026)
1.7 Active Pharmaceutical Ingredients (API) Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 Active Pharmaceutical Ingredients (API) Market Segment Analysis by Player
2.1 Global Active Pharmaceutical Ingredients (API) Sales and Market Share by Player (2016-2018)
2.2 Global Active Pharmaceutical Ingredients (API) Revenue and Market Share by Player (2016-2018)
2.3 Global Active Pharmaceutical Ingredients (API) Average Price by Player (2016-2018)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Active Pharmaceutical Ingredients (API) Market Segment Analysis by Type
3.1 Global Active Pharmaceutical Ingredients (API) Market by Type
3.1.1 Synthetic APIs
3.1.2 Biotech APIs
3.2 Global Active Pharmaceutical Ingredients (API) Sales and Market Share by Type (2013-2018)
3.3 Global Active Pharmaceutical Ingredients (API) Revenue and Market Share by Type (2013-2018)
3.4 Global Active Pharmaceutical Ingredients (API) Average Price by Type (2013-2018)
3.5 Leading Players of Active Pharmaceutical Ingredients (API) by Type in 2018
3.6 Conclusion of Segment by Type
Chapter 4 Active Pharmaceutical Ingredients (API) Market Segment Analysis by Application
4.1 Global Active Pharmaceutical Ingredients (API) Market by Application
4.1.1 CNS
4.1.2 Cardiovascular
4.1.3 Genitourinary/Hormonal Drugs
4.1.4 Respiratory
4.1.5 Rheumatology
4.2 Global Active Pharmaceutical Ingredients (API) Sales and Market Share by Application (2013-2018)
4.3 Leading Consumers of Active Pharmaceutical Ingredients (API) by Application in 2018
4.4 Conclusion of Segment by Application
Chapter 5 Active Pharmaceutical Ingredients (API) Market Segment Analysis by Sales Channel
5.1 Global Active Pharmaceutical Ingredients (API) Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Active Pharmaceutical Ingredients (API) Sales and Market Share by Sales Channel (2013-2018)
5.3 Leading Distributors/Dealers of Active Pharmaceutical Ingredients (API) by Sales Channel in 2018
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Active Pharmaceutical Ingredients (API) Market Segment Analysis by Region
6.1 Global Active Pharmaceutical Ingredients (API) Market Size and CAGR by Region (2021-2026)
6.2 Global Active Pharmaceutical Ingredients (API) Sales and Market Share by Region (2013-2018)
6.3 Global Active Pharmaceutical Ingredients (API) Revenue and Market Share by Region (2013-2018)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Active Pharmaceutical Ingredients (API) Market Share by Type
6.4.3 North America Active Pharmaceutical Ingredients (API) Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Active Pharmaceutical Ingredients (API) Market Share by Type
6.5.3 Europe Active Pharmaceutical Ingredients (API) Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Active Pharmaceutical Ingredients (API) Market Share by Type
6.6.3 Asia-Pacific Active Pharmaceutical Ingredients (API) Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Active Pharmaceutical Ingredients (API) Market Share by Type
6.7.3 South America Active Pharmaceutical Ingredients (API) Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.7.7 Chile
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Active Pharmaceutical Ingredients (API) Market Share by Type
6.8.3 Middle East & Africa Active Pharmaceutical Ingredients (API) Market Share by Application
6.8.4 Egypt
6.8.5 Saudi Arabia
6.8.6 South Africa
6.8.7 Nigeria
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Active Pharmaceutical Ingredients (API) Players
7.1 Teva
7.1.1 Company Snapshot
7.1.2 Product/Business Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.1.4 Strategy and SWOT Analysis
7.2 Mylan
7.3 DSM
7.4 Aurobindo Pharma
7.5 Aspen
7.6 Novartis
7.7 BASF
7.8 Pfizer
7.9 Huahai Pharmaceutical
7.10 Hisun Pharmaceutical
7.11 Sun Pharmaceutical Industries
7.12 Zhejiang Medicine
7.13 Dr. Reddy?s Laboratories
7.14 Zhejiang NHU
7.15 Bayer
7.16 NCPC
7.17 AbbVie
7.18 Shandong Xinhua Pharmaceutical
7.19 Northeast Pharm
7.20 Harbin Pharmaceutical
7.21 LKPC
Chapter 8 Upstream and Downstream Analysis of Active Pharmaceutical Ingredients (API)
8.1 Industrial Chain of Active Pharmaceutical Ingredients (API)
8.2 Upstream of Active Pharmaceutical Ingredients (API)
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.2.4 Manufacturing Cost Structure
8.2.5 Manufacturing Process
8.3 Downstream of Active Pharmaceutical Ingredients (API)
8.3.1 Leading Distributors/Dealers of Active Pharmaceutical Ingredients (API)
8.3.2 Leading Consumers of Active Pharmaceutical Ingredients (API)
Chapter 9 Development Trend of Active Pharmaceutical Ingredients (API) (2019-2028)
9.1 Global Active Pharmaceutical Ingredients (API) Market Size (Sales and Revenue) Forecast (2019-2028)
9.2 Global Active Pharmaceutical Ingredients (API) Market Size and CAGR Forecast by Region (2019-2028)
9.3 Global Active Pharmaceutical Ingredients (API) Market Size and CAGR Forecast by Type (2019-2028)
9.4 Global Active Pharmaceutical Ingredients (API) Market Size and CAGR Forecast by Application (2019-2028)
9.5 Global Active Pharmaceutical Ingredients (API) Market Size Forecast by Sales Channel (2019-2028)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
